Cardiac resynchronization therapy in non-ischemic cardiomyopathy: a comparative non-randomized study of His Bundle pacing versus biventricular pacing

医学 心脏再同步化治疗 心脏病学 射血分数 内科学 左束支阻滞 心力衰竭 四分位间距 QRS波群 心肌病 缺血性心肌病 冠状窦
作者
Pablo Moriña‐Vázquez,María Teresa Moraleda Salas,Adrián Rodríguez-Albarrán,Álvaro Arce‐León,José Venegas‐Gamero,Juan Manuel Fernández-Gómez,Irene Esteve‐Ruiz,Rafael Barba-Pichardo
出处
期刊:Journal of Interventional Cardiac Electrophysiology [Springer Science+Business Media]
卷期号:66 (5): 1077-1084 被引量:9
标识
DOI:10.1007/s10840-022-01192-2
摘要

Cardiac resynchronization therapy (CRT) via permanent His bundle pacing (pHBP) has gained acceptance globally, but robust studies comparing pHBP-CRT with classic CRT are lacking. In this study, we aimed to compare the improvement in left ventricular ejection fraction (LVEF) after pHBP-CRT versus classic CRT.This was a single-center study comparing a prospective series of pHBP-CRT with a historical series of CRT via classic biventricular pacing (BVP). Patients with non-ischemic cardiomyopathy, baseline LVEF < 35%, left bundle branch block (LBBB), and CRT indications were selected.Fifty-one patients underwent classic CRT and 52 patients underwent pHBP-CRT. In the classic CRT group, the median (interquartile range) basal LVEF was 30% (IQR, 29-35%) before implantation and 40% (35-48%) at follow-up. In the pHBP-CRT group, the median basal LVEF was 30% (28-34%) before implantation and 55% (45-60%) at follow-up, with significant differences between both modalities at follow-up (p = 0.001). The median long term His recruitment threshold with LBBB correction was 1.25 (1-2.5) V at 0.4 ms in cases of pHBP-CRT, compared to a left ventricular coronary sinus threshold of 1.25 (1-1.75) V in cases of classic CRT (p = 0.48). After CRT, the median paced QRS was 135 (120-145) ms for pHBP-CRT versus 140 (130-150) ms for BVP-CRT (p = 0.586).The improvement in LVEF was superior with pHBP-CRT than with classic CRT. The thresholds at follow-up were similar in both groups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
害羞寒凡发布了新的文献求助10
刚刚
2秒前
应急食品完成签到,获得积分10
8秒前
8秒前
科研通AI6.2应助SRY采纳,获得10
8秒前
wxwxwx77完成签到,获得积分10
9秒前
冷静金毛完成签到,获得积分10
10秒前
害羞寒凡完成签到,获得积分20
11秒前
Orange应助狂野半仙采纳,获得10
12秒前
13秒前
沛蓝完成签到,获得积分10
13秒前
14秒前
15秒前
蔡宇滔发布了新的文献求助10
17秒前
浮熙发布了新的文献求助10
17秒前
传奇3应助更二采纳,获得10
18秒前
njebcuiebvjc完成签到,获得积分20
19秒前
20秒前
YIDIE完成签到,获得积分10
21秒前
科研通AI2S应助111111aaa采纳,获得10
21秒前
Maestro_S应助阿叶呀采纳,获得10
21秒前
英俊的铭应助风中怜雪采纳,获得10
22秒前
害羞寒凡关注了科研通微信公众号
22秒前
英俊的铭应助咖啡豆采纳,获得10
22秒前
聪慧的梦安完成签到,获得积分10
25秒前
酷波er应助矜持采纳,获得10
25秒前
七月不远发布了新的文献求助10
28秒前
29秒前
LRH完成签到,获得积分10
30秒前
30秒前
30秒前
慕青应助科研通管家采纳,获得10
30秒前
奔跑应助科研通管家采纳,获得10
30秒前
今后应助科研通管家采纳,获得10
31秒前
SciGPT应助科研通管家采纳,获得10
31秒前
CodeCraft应助科研通管家采纳,获得10
31秒前
科目三应助科研通管家采纳,获得30
31秒前
完美世界应助科研通管家采纳,获得10
31秒前
李爱国应助科研通管家采纳,获得10
31秒前
FashionBoy应助科研通管家采纳,获得10
32秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Reducing Compassion Fatigue, Secondary Traumatic Stress and Burnout 600
Comparative Elite Sport Development Systems, Structures and Public Policy 600
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Auslegungsgeschichte 500
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
What is the Future of Psychotherapy in Digital Age? Technology, AI Bots, and Psychotherapy after Covid 444
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7637721
求助须知:如何正确求助?哪些是违规求助? 9211240
关于积分的说明 19758344
捐赠科研通 7204929
什么是DOI,文献DOI怎么找? 3275753
关于科研通互助平台的介绍 2437365
邀请新用户注册赠送积分活动 2272928